Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Andrew Alliance Secures Series B Financing

Posted in Life Sciences Investing

Andrew Alliance has announced the closing of a series B financing round.

Andrew Alliance, which is based in Switzerland and will be opening an office in Boston, is a developer of life science robotics. In January 2013, Andrew Alliance introduced Andrew, a co-worker robot designed to assist scientists by taking over the manipulation of commercial laboratory pipettes.

Funding for the round came from Omega Funds, which specializes in late-stage life science investments.

Andrew Alliance indicated the funding would go toward expanding the reach of its robots through new developments and the establishment of commercial operations in the U.S. market.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree